Reply: Unraveling the Hypocalcemic Response to 177Lu-Prostate-Specific Membrane Antigen Therapy

J Nucl Med. 2024 Feb 1;65(2):333-334. doi: 10.2967/jnumed.123.266768.
No abstract available

Publication types

  • Letter

MeSH terms

  • Dipeptides
  • Heterocyclic Compounds, 1-Ring
  • Humans
  • Lutetium
  • Male
  • Prostate*
  • Prostate-Specific Antigen
  • Prostatic Neoplasms, Castration-Resistant*

Substances

  • Prostate-Specific Antigen
  • Lutetium
  • Dipeptides
  • Heterocyclic Compounds, 1-Ring